Phase III Prospective Randomized Trial Comparing Ramosetron Versus Ondansetron for Radiotherapy Induced Nausea and Vomiting in the Treatment of Gastrointestinal Cancer.

Trial Profile

Phase III Prospective Randomized Trial Comparing Ramosetron Versus Ondansetron for Radiotherapy Induced Nausea and Vomiting in the Treatment of Gastrointestinal Cancer.

Completed
Phase of Trial: Phase III

Latest Information Update: 25 Feb 2011

At a glance

  • Drugs Ramosetron (Primary) ; Ondansetron
  • Indications Radiotherapy-induced nausea and vomiting
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Feb 2011 Actual end date (Feb 20101) added as reported by ClinicalTrials.gov.
    • 25 Feb 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 10 Sep 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top